Acinetobacter baumannii OmpA Is a Selective Antibiotic Permeant Porin

ACS Infectious Diseases

Volumn 4, Issue 3, 2018, Pages 373-381

  Iyer, Ramkumar ^a   Moussa, Samir H ^a   Durand Réville, Thomas F ^a   Tommasi, Ruben ^a   Miller, Alita ^a  

^a Entasis Therapeutics   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; BETA LACTAMASE INHIBITOR; CHLORAMPHENICOL; COLISTIN; ETX 2514; IMIPENEM; OUTER MEMBRANE PROTEIN; PORIN; RIFAMPICIN; SULBACTAM; TETRACYCLINE; UNCLASSIFIED DRUG; ANTIINFECTIVE AGENT; AZABICYCLO DERIVATIVE; ETX2514; OMPA OUTER MEMBRANE PROTEINS;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENE; BACTERIAL LOAD; BACTERIAL OUTER MEMBRANE; BACTERIAL STRAIN; BACTERIAL SURVIVAL; BACTERIAL VIRULENCE; BACTERIUM ISOLATE; BACTERIUM MUTANT; COLONY FORMING UNIT; COMBINATION DRUG THERAPY; CONTROLLED STUDY; DRUG POTENTIATION; ESCHERICHIA COLI; FEMALE; GENE EXPRESSION SYSTEM; HETEROLOGOUS EXPRESSION; MINIMUM INHIBITORY CONCENTRATION; MOUSE; NONHUMAN; OMPA GENE; PRIORITY JOURNAL; SEQUENCE HOMOLOGY; STRUCTURE ACTIVITY RELATION; ANIMAL; DISEASE MODEL; ENZYMOLOGY; METABOLISM; MICROBIOLOGY; PHYSIOLOGY; REPRODUCTIVE FITNESS; TRANSPORT AT THE CELLULAR LEVEL;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTIONS; ANIMALS; ANTI-BACTERIAL AGENTS; AZABICYCLO COMPOUNDS; BACTERIAL OUTER MEMBRANE PROTEINS; BIOLOGICAL TRANSPORT; DISEASE MODELS, ANIMAL; GENETIC FITNESS; MICE; PORINS; STRUCTURE-ACTIVITY RELATIONSHIP; SULBACTAM;

EID: 85043484992     PISSN: None     EISSN: 23738227     Source Type: Journal    
DOI: 10.1021/acsinfecdis.7b00168     Document Type: Article

References (62)

1. Luo, G., Lin, L., Ibrahim, A. S., Baquir, B., Pantapalangkoor, P., Bonomo, R. A., Doi, Y., Adams, M. D., Russo, T. A., and Spellberg, B. (2012) Active and passive immunization protects against lethal, extreme drug resistant- Acinetobacter baumannii infection. PLoS One 7 (1), e29446, 10.1371/journal.pone.0029446
2. Viehman, J. A., Nguyen, M. H., and Doi, Y. (2014) Treatment options for carbapenem-resistant and extensively drug-resistant Acinetobacter baumannii infections. Drugs 74 (12), 1315-1333, 10.1007/s40265-014-0267-8
3. Fishbain, J. and Peleg, A. Y. (2010) Treatment of Acinetobacter infections. Clin. Infect. Dis. 51 (1), 79-84, 10.1086/653120
4. Peleg, A. Y., Seifert, H., and Paterson, D. L. (2008) Acinetobacter baumannii: emergence of a successful pathogen. Clin Microbiol Rev. 21 (3), 538-582, 10.1128/CMR.00058-07
5. Turton, J. F., Ward, M. E., Woodford, N., Kaufmann, M. E., Pike, R., Livermore, D. M., and Pitt, T. L. (2006) The role of ISAba1 in expression of OXA carbapenemase genes in Acinetobacter baumannii. FEMS Microbiol. Lett. 258 (1), 72-77, 10.1111/j.1574-6968.2006.00195.x
6. Kim, W. Y., Moon, J. Y., Huh, J. W., Choi, S. H., Lim, C. M., Koh, Y., Chong, Y. P., and Hong, S. B. (2016) Comparable Efficacy of Tigecycline versus Colistin Therapy for Multidrug-Resistant and Extensively Drug-Resistant Acinetobacter baumannii Pneumonia in Critically Ill Patients. PLoS One 11 (3), e0150642, 10.1371/journal.pone.0150642
7. Pogue, J. M., Mann, T., Barber, K. E., and Kaye, K. S. (2013) Carbapenem-resistant Acinetobacter baumannii: epidemiology, surveillance and management. Expert Rev. Anti-Infect. Ther. 11 (4), 383-393, 10.1586/eri.13.14
8. Islam, M. A., Islam, M., Hasan, R., Hossain, M. I., Nabi, A., Rahman, M., Goessens, W. H. F., Endtz, H. P., Boehm, A. B., and Faruque, S. M. (2017) Environmental spread of NDM-1-producing multi-drug resistant bacteria in Dhaka, Bangladesh. Appl. Environ. Microbiol. 83 (15), e00793-17, 10.1128/AEM.00793-17
9. Ribera, A., Roca, I., Ruiz, J., Gibert, I., and Vila, J. (2003) Partial characterization of a transposon containing the tet(A) determinant in a clinical isolate of Acinetobacter baumannii. J. Antimicrob. Chemother. 52 (3), 477-480, 10.1093/jac/dkg344
10. Zhu, Y., Yi, Y., Liu, F., Lv, N., Yang, X., Li, J., Hu, Y., and Zhu, B. (2014) Distribution and molecular profiling of class 1 integrons in MDR Acinetobacter baumannii isolates and whole genome-based analysis of antibiotic resistance mechanisms in a representative strain. Microbiol. Res. 169 (11), 811-816, 10.1016/j.micres.2014.04.002
11. Yoon, E. J., Chabane, Y. N., Goussard, S., Snesrud, E., Courvalin, P., De, E., and Grillot-Courvalin, C. (2015) Contribution of resistance-nodulation-cell division efflux systems to antibiotic resistance and biofilm formation in Acinetobacter baumannii. mBio 6 (2), e00309-15, 10.1128/mBio.00309-15
12. Sato, K. and Nakae, T. (1991) Outer membrane permeability of Acinetobacter calcoaceticus and its implication in antibiotic resistance. J. Antimicrob. Chemother. 28 (1), 35-45, 10.1093/jac/28.1.35
13. Nikaido, H. (2003) Molecular basis of bacterial outer membrane permeability revisited. Microbiol Mol. Biol. Rev. 67 (4), 593-656, 10.1128/MMBR.67.4.593-656.2003
14. Delcour, A. H. (2009) Outer membrane permeability and antibiotic resistance. Biochim. Biophys. Acta, Proteins Proteomics 1794 (5), 808-816, 10.1016/j.bbapap.2008.11.005
15. Hancock, R. E. and Brinkman, F. S. (2002) Function of pseudomonas porins in uptake and efflux. Annu. Rev. Microbiol. 56, 17-38, 10.1146/annurev.micro.56.012302.160310
16. Pages, J. M., James, C. E., and Winterhalter, M. (2008) The porin and the permeating antibiotic: a selective diffusion barrier in Gram-negative bacteria. Nat. Rev. Microbiol. 6 (12), 893-903, 10.1038/nrmicro1994
17. Wang, Y. (2002) The function of OmpA in Escherichia coli. Biochem. Biophys. Res. Commun. 292 (2), 396-401, 10.1006/bbrc.2002.6657
18. Lee, C. R., Lee, J. H., Park, M., Park, K. S., Bae, I. K., Kim, Y. B., Cha, C. J., Jeong, B. C., and Lee, S. H. (2017) Biology of Acinetobacter baumannii: Pathogenesis, Antibiotic Resistance Mechanisms, and Prospective Treatment Options. Front. Cell. Infect. Microbiol. 7 (55), 1-35, 10.3389/fcimb.2017.00055
19. Samsudin, F., Ortiz-Suarez, M. L., Piggot, T. J., Bond, P. J., and Khalid, S. (2016) OmpA: A Flexible Clamp for Bacterial Cell Wall Attachment. Structure 24 (12), 2227-2235, 10.1016/j.str.2016.10.009
20. Mushtaq, A. U., Park, J. S., Bae, S. H., Kim, H. Y., Yeo, K. J., Hwang, E., Lee, K. Y., Jee, J. G., Cheong, H. K., and Jeon, Y. H. (2017) Ligand-Mediated Folding of the OmpA Periplasmic Domain from Acinetobacter baumannii. Biophys. J. 112 (10), 2089-2098, 10.1016/j.bpj.2017.04.015
21. Park, J. S., Lee, W. C., Yeo, K. J., Ryu, K. S., Kumarasiri, M., Hesek, D., Lee, M., Mobashery, S., Song, J. H., Kim, S. I., Lee, J. C., Cheong, C., Jeon, Y. H., and Kim, H. Y. (2012) Mechanism of anchoring of OmpA protein to the cell wall peptidoglycan of the gram-negative bacterial outer membrane. FASEB J. 26 (1), 219-228, 10.1096/fj.11-188425
22. Pautsch, A. and Schulz, G. E. (1998) Structure of the outer membrane protein A transmembrane domain. Nat. Struct. Biol. 5 (11), 1013-1017, 10.1038/2983
23. Sugawara, E. and Nikaido, H. (2012) OmpA is the principal nonspecific slow porin of Acinetobacter baumannii. J. Bacteriol. 194 (15), 4089-4096, 10.1128/JB.00435-12
24. Tommasi, R., Brown, D. G., Walkup, G. K., Manchester, J. I., and Miller, A. A. (2015) ESKAPEing the labyrinth of antibacterial discovery. Nat. Rev. Drug Discovery 14 (8), 529-542, 10.1038/nrd4572
25. Silver, L. L. (2011) Challenges of antibacterial discovery. Clin Microbiol Rev. 24 (1), 71-109, 10.1128/CMR.00030-10
26. Smani, Y., Fabrega, A., Roca, I., Sanchez-Encinales, V., Vila, J., and Pachon, J. (2014) Role of OmpA in the multidrug resistance phenotype of Acinetobacter baumannii. Antimicrob. Agents Chemother. 58 (3), 1806-1808, 10.1128/AAC.02101-13
27. Kwon, H. I., Kim, S., Oh, M. H., Na, S. H., Kim, Y. J., Jeon, Y. H., and Lee, J. C. (2017) Outer membrane protein A contributes to antimicrobial resistance of Acinetobacter baumannii through the OmpA-like domain. J. Antimicrob. Chemother. 72, 3012, 10.1093/jac/dkx257
28. Iyer, R., Sylvester, M. A., Velez-Vega, C., Tommasi, R., Durand-Reville, T. F., and Miller, A. A. (2017) Whole-Cell-Based Assay To Evaluate Structure Permeation Relationships for Carbapenem Passage through the Pseudomonas aeruginosa Porin OprD. ACS Infect. Dis. 3 (4), 310-319, 10.1021/acsinfecdis.6b00197
29. Durand-Reville, T. F., Guler, S., Comita-Prevoir, J., Chen, B., Bifulco, N., Huynh, H., Lahiri, S., Shapiro, A. B., McLeod, S. M., Carter, N. M., Moussa, S. H., Velez-Vega, C., Olivier, N. B., McLaughlin, R., Gao, N., Thresher, J., Palmer, T., Andrews, B., Giacobbe, R. A., Newman, J. V., Ehmann, D. E., de Jonge, B., O'Donnell, J., Mueller, J. P., Tommasi, R. A., and Miller, A. A. (2017) ETX2514 is a broad-spectrum b-lactamase inhibitor for the treatment of drug-resistant Gram-negative bacteria including Acinetobacter baumannii. Nat. Microbiol 2, 17104, 10.1038/nmicrobiol.2017.104
30. Penwell, W. F., Shapiro, A. B., Giacobbe, R. A., Gu, R. F., Gao, N., Thresher, J., McLaughlin, R. E., Huband, M. D., DeJonge, B. L., Ehmann, D. E., and Miller, A. A. (2015) Molecular mechanisms of sulbactam antibacterial activity and resistance determinants in Acinetobacter baumannii. Antimicrob. Agents Chemother. 59 (3), 1680-1689, 10.1128/AAC.04808-14
31. Levin, A. S. and Oliveira, M. S. (2008) The challenge of multidrug resistance: the treatment of gram-negative rod infections. Shock 30 (Suppl 1), 30-33, 10.1097/SHK.0b013e3181819cb8
32. Shapiro, A. B. (2017) Kinetics of Sulbactam Hydrolysis by beta-Lactamases, and Kinetics of beta-Lactamase Inhibition by Sulbactam. Antimicrob. Agents Chemother. 61 (12), e01612-17, 10.1128/AAC.01612-17
33. Cohen, T. S., Hilliard, J. J., Jones-Nelson, O., Keller, A. E., O'Day, T., Tkaczyk, C., DiGiandomenico, A., Hamilton, M., Pelletier, M., Wang, Q., Diep, B. A., Le, V. T., Cheng, L., Suzich, J., Stover, C. K., and Sellman, B. R. (2016) Staphylococcus aureus alpha toxin potentiates opportunistic bacterial lung infections. Sci. Transl. Med. 8 (329), 329ra31, 10.1126/scitranslmed.aad9922
34. Khlebnikov, A., Risa, O., Skaug, T., Carrier, T. A., and Keasling, J. D. (2000) Regulatable arabinose-inducible gene expression system with consistent control in all cells of a culture. J. Bacteriol. 182 (24), 7029-7034, 10.1128/JB.182.24.7029-7034.2000
35. Khlebnikov, A., Datsenko, K. A., Skaug, T., Wanner, B. L., and Keasling, J. D. (2001) Homogeneous expression of the P(BAD) promoter in Escherichia coli by constitutive expression of the low-affinity high-capacity AraE transporter. Microbiology 147 (12), 3241-3247, 10.1099/00221287-147-12-3241
36. Chong, Z. S., Woo, W. F., and Chng, S. S. (2015) Osmoporin OmpC forms a complex with MlaA to maintain outer membrane lipid asymmetry in Escherichia coli. Mol. Microbiol. 98 (6), 1133-1146, 10.1111/mmi.13202
37. Lister, P. D., Wolter, D. J., and Hanson, N. D. (2009) Antibacterial-resistant Pseudomonas aeruginosa: clinical impact and complex regulation of chromosomally encoded resistance mechanisms. Clin Microbiol Rev. 22 (4), 582-610, 10.1128/CMR.00040-09
38. Gaddy, J. A., Tomaras, A. P., and Actis, L. A. (2009) The Acinetobacter baumannii 19606 OmpA protein plays a role in biofilm formation on abiotic surfaces and in the interaction of this pathogen with eukaryotic cells. Infect. Immun. 77 (8), 3150-3160, 10.1128/IAI.00096-09
39. Wang, N., Ozer, E. A., Mandel, M. J., and Hauser, A. R. (2014) Genome-wide identification of Acinetobacter baumannii genes necessary for persistence in the lung. mBio 5 (3), e01163-14, 10.1128/mBio.01163-14
40. Sanchez-Encinales, V., Alvarez-Marin, R., Pachon-Ibanez, M. E., Fernandez-Cuenca, F., Pascual, A., Garnacho-Montero, J., Martinez-Martinez, L., Vila, J., Tomas, M. M., Cisneros, J. M., Bou, G., Rodriguez-Bano, J., Pachon, J., and Smani, Y. (2017) Overproduction of Outer Membrane Protein A by Acinetobacter baumannii as a Risk Factor for Nosocomial Pneumonia, Bacteremia, and Mortality Rate Increase. J. Infect. Dis. 215 (6), 966-974, 10.1093/infdis/jix010
41. Ahmad, T. A., Tawfik, D. M., Sheweita, S. A., Haroun, M., and El-Sayed, L. H. (2016) Development of immunization trials against Acinetobacter baumannii. Trials in Vaccinology 5, 53-60, 10.1016/j.trivac.2016.03.001
42. Luo, G., Lin, L., Ibrahim, A. I., and Spellberg, B. (2011) The OmpA vaccine protects mice against lethal, extreme drug resistant- Acinetobacter baumannii infection. J. Immunol. 186 (1), 106.20
43. Hearn, E. M., Patel, D. R., Lepore, B. W., Indic, M., and van den Berg, B. (2009) Transmembrane passage of hydrophobic compounds through a protein channel wall. Nature 458 (7236), 367-370, 10.1038/nature07678
44. Moraes, T. F., Bains, M., Hancock, R. E., and Strynadka, N. C. (2007) An arginine ladder in OprP mediates phosphate-specific transfer across the outer membrane. Nat. Struct. Mol. Biol. 14 (1), 85-87, 10.1038/nsmb1189
45. Eren, E., Vijayaraghavan, J., Liu, J., Cheneke, B. R., Touw, D. S., Lepore, B. W., Indic, M., Movileanu, L., and van den Berg, B. (2012) Substrate specificity within a family of outer membrane carboxylate channels. PLoS Biol. 10 (1), e1001242, 10.1371/journal.pbio.1001242
46. Confer, A. W. and Ayalew, S. (2013) The OmpA family of proteins: roles in bacterial pathogenesis and immunity. Vet. Microbiol. 163 (3-4), 207-222, 10.1016/j.vetmic.2012.08.019
47. Schweppe, D. K., Harding, C., Chavez, J. D., Wu, X., Ramage, E., Singh, P. K., Manoil, C., and Bruce, J. E. (2015) Host-Microbe Protein Interactions during Bacterial Infection. Chem. Biol. 22 (11), 1521-1530, 10.1016/j.chembiol.2015.09.015
48. Ochs, M. M., McCusker, M. P., Bains, M., and Hancock, R. E. (1999) Negative regulation of the Pseudomonas aeruginosa outer membrane porin OprD selective for imipenem and basic amino acids. Antimicrob. Agents Chemother. 43 (5), 1085-1090
49. Kim, S. W., Oh, M. H., Jun, S. H., Jeon, H., Kim, S. I., Kim, K., Lee, Y. C., and Lee, J. C. (2016) Outer membrane Protein A plays a role in pathogenesis of Acinetobacter nosocomialis. Virulence 7 (4), 413-426, 10.1080/21505594.2016.1140298
50. Kos, V. N., McLaughlin, R. E., and Gardner, H. A. (2016) Identification of unique in-frame deletions in OprD among clinical isolates of Pseudomonas aeruginosa. Pathog. Dis. 74 (4), ftw031, 10.1093/femspd/ftw031
51. Zhang, Y., Jiang, X., Wang, Y., Li, G., Tian, Y., Liu, H., Ai, F., Ma, Y., Wang, B., Ruan, F., and Rajakumar, K. (2014) Contribution of b-lactamases and porin proteins OmpK35 and OmpK36 to carbapenem resistance in clinical isolates of KPC-2-producing Klebsiella pneumoniae. Antimicrob. Agents Chemother. 58 (2), 1214-1217, 10.1128/AAC.02045-12
52. McLeod, S. M., Shapiro, A. B., Moussa, S. H., Johnstone, M., McLaughlin, R., De Jonge, B., and Miller, A. A. (2017) Antimicrob. Agents Chemother. AAC.01576-17, 10.1128/AAC.01576-17
53. Hancock, R. E. and Bell, A. (1988) Antibiotic uptake into gram-negative bacteria. Eur. J. Clin. Microbiol. Infect. Dis. 7 (6), 713-720, 10.1007/BF01975036
54. Coyne, S., Courvalin, P., and Perichon, B. (2011) Efflux-mediated antibiotic resistance in Acinetobacter spp. Antimicrob. Agents Chemother. 55 (3), 947-953, 10.1128/AAC.01388-10
55. Catel-Ferreira, M., Coadou, G., Molle, V., Mugnier, P., Nordmann, P., Siroy, A., Jouenne, T., and De, E. (2011) Structure-function relationships of CarO, the carbapenem resistance-associated outer membrane protein of Acinetobacter baumannii. J. Antimicrob. Chemother. 66 (9), 2053-2056, 10.1093/jac/dkr267
56. Zahn, M., D'Agostino, T., Eren, E., Basle, A., Ceccarelli, M., and van den Berg, B. (2015) Small-Molecule Transport by CarO, an Abundant Eight-Stranded b-Barrel Outer Membrane Protein from Acinetobacter baumannii. J. Mol. Biol. 427 (14), 2329-2339, 10.1016/j.jmb.2015.03.016
57. Mussi, M. A., Relling, V. M., Limansky, A. S., and Viale, A. M. (2007) CarO, an Acinetobacter baumannii outer membrane protein involved in carbapenem resistance, is essential for L-ornithine uptake. FEBS Lett. 581 (29), 5573-5578, 10.1016/j.febslet.2007.10.063
58. Eren, E., Parkin, J., Adelanwa, A., Cheneke, B., Movileanu, L., Khalid, S., and van den Berg, B. (2013) Toward understanding the outer membrane uptake of small molecules by Pseudomonas aeruginosa. J. Biol. Chem. 288 (17), 12042-12053, 10.1074/jbc.M113.463570
59. Isabella, V. M., Campbell, A. J., Manchester, J., Sylvester, M., Nayar, A. S., Ferguson, K. E., Tommasi, R., and Miller, A. A. (2015) Toward the rational design of carbapenem uptake in Pseudomonas aeruginosa. Chem. Biol. 22 (4), 535-547, 10.1016/j.chembiol.2015.03.018
60. Miller, J. H. (1972) Experiments in Molecular Genetics, 3 ed., Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
61. Gerber, A. U., Craig, W. A., Brugger, H. P., Feller, C., Vastola, A. P., and Brandel, J. (1983) Impact of dosing intervals on activity of gentamicin and ticarcillin against Pseudomonas aeruginosa in granulocytopenic mice. J. Infect. Dis. 147 (5), 910-917, 10.1093/infdis/147.5.910
62. McGuire, H., Bist, S., Bifulco, N., Zhao, L., Wu, Y., Huynh, H., Xiong, H., Comita-Prevoir, J., Dussault, D., Geng, B., Chen, B., Durand-Reville, T. F., and Guler, S. (2016) β-lactamase inhibitor compounds. U.S. Patent 9309245.